Protara Therapeutics Stock Price History
| TARA Stock | USD 3.35 0.02 0.60% |
Below is the normalized historical share price chart for Protara Therapeutics extending back to October 22, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protara Therapeutics stands at 3.35, as last reported on the 23rd of July, with the highest price reaching 3.35 and the lowest price hitting 3.33 during the day.
If you're considering investing in Protara Stock, it is important to understand the factors that can impact its price. Protara Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0482, which implies the firm had a -0.0482 % return per unit of risk over the last 3 months. Protara Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Protara Therapeutics' Risk Adjusted Performance of (0.03), variance of 20.89, and Coefficient Of Variation of (2,653) to confirm the risk estimate we provide. At present, Protara Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 21.6 M, whereas Other Stockholder Equity is forecasted to decline to about 217.2 M. . As of July 23, 2025, Price To Sales Ratio is expected to decline to 8.65. In addition to that, Price Earnings Ratio is expected to decline to -2.56. Protara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2014 | 200 Day MA 3.6646 | 50 Day MA 3.1335 | Beta 1.36 |
Sharpe Ratio = -0.0482
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TARA |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Protara Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protara Therapeutics by adding Protara Therapeutics to a well-diversified portfolio.
Protara Therapeutics Stock Price History Chart
There are several ways to analyze Protara Stock price data. The simplest method is using a basic Protara candlestick price chart, which shows Protara Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 25, 2025 | 4.32 |
| Lowest Price | July 2, 2025 | 2.78 |
Protara Therapeutics July 23, 2025 Stock Price Synopsis
Various analyses of Protara Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Protara Stock. It can be used to describe the percentage change in the price of Protara Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Protara Stock.| Protara Therapeutics Price Daily Balance Of Power | 1.00 | |
| Protara Therapeutics Price Rate Of Daily Change | 1.01 | |
| Protara Therapeutics Price Action Indicator | 0.02 |
Protara Therapeutics July 23, 2025 Stock Price Analysis
Protara Stock Price History Data
The price series of Protara Therapeutics for the period between Thu, Apr 24, 2025 and Wed, Jul 23, 2025 has a statistical range of 1.54 with a coefficient of variation of 9.98. The price distribution for the period has arithmetic mean of 3.27. The median price for the last 90 days is 3.22. The company completed stock split (1:40) on 10th of January 2020. Protara Therapeutics had dividends distributed to its stock-holders on 2020-01-10.| Open | High | Low | Close | Volume | ||
07/23/2025 | 3.33 | 3.35 | 3.33 | 3.35 | ||
| 07/22/2025 | 3.42 | 3.45 | 3.26 | 3.33 | 287,003 | |
07/21/2025 | 3.13 | 3.43 | 3.09 | 3.42 | 300,025 | |
07/18/2025 | 3.18 | 3.20 | 3.07 | 3.08 | 123,405 | |
07/17/2025 | 3.17 | 3.20 | 3.12 | 3.14 | 120,194 | |
07/16/2025 | 3.08 | 3.18 | 3.06 | 3.15 | 170,385 | |
| 07/15/2025 | 3.18 | 3.23 | 3.03 | 3.05 | 180,841 | |
07/14/2025 | 3.03 | 3.17 | 3.02 | 3.16 | 105,954 | |
07/11/2025 | 3.10 | 3.21 | 3.03 | 3.05 | 118,189 | |
07/10/2025 | 3.19 | 3.22 | 3.12 | 3.12 | 150,551 | |
07/09/2025 | 3.04 | 3.23 | 3.00 | 3.22 | 357,990 | |
07/08/2025 | 2.82 | 3.04 | 2.81 | 3.03 | 293,024 | |
07/07/2025 | 2.89 | 2.94 | 2.80 | 2.80 | 340,021 | |
07/03/2025 | 2.80 | 2.92 | 2.80 | 2.89 | 133,655 | |
07/02/2025 | 2.79 | 2.87 | 2.77 | 2.78 | 338,280 | |
| 07/01/2025 | 3.06 | 3.10 | 2.79 | 2.80 | 531,877 | |
| 06/30/2025 | 2.86 | 3.07 | 2.81 | 3.03 | 730,719 | |
| 06/27/2025 | 3.00 | 3.05 | 2.85 | 2.88 | 4,313,150 | |
06/26/2025 | 2.90 | 3.03 | 2.89 | 2.98 | 277,704 | |
06/25/2025 | 3.08 | 3.08 | 2.89 | 2.89 | 305,620 | |
| 06/24/2025 | 2.93 | 3.10 | 2.87 | 3.06 | 314,505 | |
06/23/2025 | 3.03 | 3.09 | 2.87 | 2.88 | 366,884 | |
06/20/2025 | 3.02 | 3.09 | 2.97 | 3.05 | 321,248 | |
06/18/2025 | 3.08 | 3.14 | 2.98 | 2.98 | 191,898 | |
06/17/2025 | 3.15 | 3.24 | 3.06 | 3.06 | 162,552 | |
06/16/2025 | 3.17 | 3.23 | 3.13 | 3.17 | 134,748 | |
06/13/2025 | 3.22 | 3.27 | 3.12 | 3.14 | 165,447 | |
| 06/12/2025 | 3.43 | 3.46 | 3.24 | 3.26 | 210,611 | |
06/11/2025 | 3.38 | 3.51 | 3.27 | 3.29 | 172,505 | |
06/10/2025 | 3.26 | 3.40 | 3.23 | 3.37 | 317,436 | |
06/09/2025 | 3.50 | 3.50 | 3.26 | 3.27 | 263,535 | |
06/06/2025 | 3.15 | 3.43 | 3.15 | 3.34 | 362,823 | |
06/05/2025 | 3.22 | 3.27 | 3.12 | 3.12 | 173,095 | |
| 06/04/2025 | 3.28 | 3.34 | 3.20 | 3.22 | 125,439 | |
06/03/2025 | 3.33 | 3.33 | 3.21 | 3.28 | 258,249 | |
| 06/02/2025 | 3.08 | 3.36 | 3.08 | 3.30 | 413,363 | |
05/30/2025 | 3.13 | 3.18 | 3.02 | 3.04 | 340,696 | |
05/29/2025 | 3.17 | 3.23 | 3.13 | 3.13 | 150,078 | |
05/28/2025 | 3.16 | 3.24 | 3.10 | 3.15 | 257,380 | |
05/27/2025 | 3.23 | 3.34 | 3.16 | 3.16 | 242,764 | |
05/23/2025 | 3.15 | 3.29 | 3.11 | 3.13 | 372,832 | |
05/22/2025 | 3.31 | 3.31 | 3.16 | 3.17 | 466,913 | |
05/21/2025 | 3.43 | 3.47 | 3.23 | 3.25 | 309,023 | |
05/20/2025 | 3.42 | 3.57 | 3.42 | 3.48 | 336,814 | |
05/19/2025 | 3.18 | 3.45 | 3.15 | 3.42 | 302,110 | |
05/16/2025 | 3.13 | 3.22 | 3.08 | 3.19 | 271,879 | |
| 05/15/2025 | 3.10 | 3.12 | 3.00 | 3.11 | 297,534 | |
05/14/2025 | 3.24 | 3.27 | 3.11 | 3.13 | 256,116 | |
05/13/2025 | 3.32 | 3.34 | 3.17 | 3.22 | 308,209 | |
05/12/2025 | 3.42 | 3.42 | 3.20 | 3.27 | 283,471 | |
05/09/2025 | 3.37 | 3.49 | 3.21 | 3.24 | 275,297 | |
05/08/2025 | 3.42 | 3.51 | 3.28 | 3.37 | 275,961 | |
05/07/2025 | 3.37 | 3.41 | 3.27 | 3.35 | 252,041 | |
05/06/2025 | 3.36 | 3.49 | 3.31 | 3.37 | 372,914 | |
05/05/2025 | 3.56 | 3.64 | 3.38 | 3.39 | 172,114 | |
05/02/2025 | 3.46 | 3.70 | 3.43 | 3.58 | 493,583 | |
05/01/2025 | 3.56 | 3.60 | 3.41 | 3.46 | 446,121 | |
04/30/2025 | 3.35 | 3.55 | 3.28 | 3.50 | 559,350 | |
04/29/2025 | 3.54 | 3.56 | 3.36 | 3.40 | 651,441 | |
04/28/2025 | 4.09 | 4.09 | 3.11 | 3.52 | 2,628,357 | |
04/25/2025 | 4.19 | 4.50 | 4.10 | 4.32 | 440,729 |
About Protara Therapeutics Stock history
Protara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protara Therapeutics stock prices may prove useful in developing a viable investing in Protara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 20.6 M | 21.6 M | |
| Net Loss | -59.4 M | -56.4 M |
Protara Therapeutics Quarterly Net Working Capital |
|
Protara Therapeutics Stock Technical Analysis
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Protara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |